Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Revenues $ 0 $ 0 $ 0 $ 0
Costs and Expenses        
Operating expenses 230,000 297,000 586,000 1,242,000
Research and development expenses 152,000 81,000 259,000 308,000
Loss from operations (382,000) (378,000) (845,000) (1,550,000)
Other expense        
Interest and financing expense (141,000) (58,000) (323,000) (493,000)
Net loss $ (523,000) $ (436,000) $ (1,168,000) $ (2,043,000)
Net loss per common share, basic and diluted $ (0.00) $ (0.00) $ (0.00) $ (0.01)
Weighted average common shares outstanding, basic and diluted 343,682,057 319,326,044 331,184,719 315,128,749